1. Home
  2. WS vs NVAX Comparison

WS vs NVAX Comparison

Compare WS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WS
  • NVAX
  • Stock Information
  • Founded
  • WS 1955
  • NVAX 1987
  • Country
  • WS United States
  • NVAX United States
  • Employees
  • WS N/A
  • NVAX N/A
  • Industry
  • WS
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WS
  • NVAX Health Care
  • Exchange
  • WS Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • WS 1.4B
  • NVAX 1.3B
  • IPO Year
  • WS N/A
  • NVAX 1995
  • Fundamental
  • Price
  • WS $23.49
  • NVAX $5.62
  • Analyst Decision
  • WS Buy
  • NVAX Buy
  • Analyst Count
  • WS 1
  • NVAX 6
  • Target Price
  • WS $34.00
  • NVAX $17.83
  • AVG Volume (30 Days)
  • WS 406.2K
  • NVAX 4.0M
  • Earning Date
  • WS 03-19-2025
  • NVAX 05-09-2025
  • Dividend Yield
  • WS 2.72%
  • NVAX N/A
  • EPS Growth
  • WS N/A
  • NVAX N/A
  • EPS
  • WS 2.14
  • NVAX N/A
  • Revenue
  • WS $3,171,400,000.00
  • NVAX $682,162,000.00
  • Revenue This Year
  • WS N/A
  • NVAX N/A
  • Revenue Next Year
  • WS N/A
  • NVAX $5.13
  • P/E Ratio
  • WS $12.08
  • NVAX N/A
  • Revenue Growth
  • WS N/A
  • NVAX N/A
  • 52 Week Low
  • WS $23.11
  • NVAX $3.81
  • 52 Week High
  • WS $47.19
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • WS 33.69
  • NVAX 23.38
  • Support Level
  • WS $24.70
  • NVAX $7.47
  • Resistance Level
  • WS $25.97
  • NVAX $7.81
  • Average True Range (ATR)
  • WS 1.22
  • NVAX 0.34
  • MACD
  • WS -0.10
  • NVAX -0.21
  • Stochastic Oscillator
  • WS 6.42
  • NVAX 8.39

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: